| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2758 | 2020 |
| Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults L Coughlan, S Sridhar, R Payne, M Edmans, A Milicic, N Venkatraman, ... EBioMedicine 29, 146-154, 2018 | 146 | 2018 |
| Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions RO Payne, SE Silk, SC Elias, K Miura, A Diouf, F Galaway, H De Graaf, ... JCI insight 2 (21), 2017 | 137 | 2017 |
| Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane … RO Payne, KH Milne, SC Elias, NJ Edwards, AD Douglas, RE Brown, ... The Journal of infectious diseases 213 (11), 1743-1751, 2016 | 113 | 2016 |
| Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara … T Rampling, KJ Ewer, G Bowyer, CM Bliss, NJ Edwards, D Wright, ... The Journal of infectious diseases 214 (5), 772-781, 2016 | 86 | 2016 |
| Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results M Tebruegge, H de Graaf, P Sukhtankar, P Elkington, B Marshall, ... Journal of clinical microbiology 52 (7), 2694-2697, 2014 | 73 | 2014 |
| Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP T Rampling, KJ Ewer, G Bowyer, NJ Edwards, D Wright, S Sridhar, ... NPJ vaccines 3 (1), 49, 2018 | 55 | 2018 |
| Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis A Edwards, Y Gao, RN Allan, D Ball, H De Graaf, T Coelho, V Clifford, ... Thorax 72 (10), 946-949, 2017 | 54 | 2017 |
| Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization H de Graaf, M Ibrahim, AR Hill, D Gbesemete, AT Vaughan, A Gorringe, ... Clinical infectious diseases 71 (2), 403-411, 2020 | 53 | 2020 |
| Severe enterovirus infections in hospitalized children in the South of England: clinical phenotypes and causative genotypes H de Graaf, E Pelosi, A Cooper, J Pappachan, K Sykes, I MacIntosh, ... The Pediatric infectious disease journal 35 (7), 723-727, 2016 | 47 | 2016 |
| Immunocompromised children and young people are at no increased risk of severe COVID-19 H Chappell, R Patel, C Driessens, AW Tarr, WL Irving, PJ Tighe, ... Journal of Infection 84 (1), 31-39, 2022 | 40 | 2022 |
| Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model H De Graaf, D Gbesemete, AR Gorringe, DA Diavatopoulos, KE Kester, ... BMJ open 7 (10), e018594, 2017 | 34 | 2017 |
| Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a phase I first-in-human trial H De Graaf, RO Payne, I Taylor, K Miura, CA Long, SC Elias, M Zaric, ... Frontiers in Immunology 12, 694759, 2021 | 32 | 2021 |
| Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature H de Graaf, S Pai, DA Burns, JA Karas, DA Enoch, SN Faust European Journal of Clinical Microbiology & Infectious Diseases 34, 1281-1287, 2015 | 29 | 2015 |
| Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study H De Graaf, P Sukhtankar, B Arch, N Ahmad, A Lees, A Bennett, ... Health Technology Assessment 21 (48), 2017 | 27 | 2017 |
| Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation D Gbesemete, M Barker, WT Lawrence, D Watson, H De Graaf, RC Read BMC medicine 18 (1), 209, 2020 | 24 | 2020 |
| Fluarix quadrivalent vaccine for influenza H Graaf, SN Faust Expert review of vaccines 14 (8), 1055-1063, 2015 | 21 | 2015 |
| Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome M Tebruegge, C Jones, H De Graaf, P Sukhtankar, RN Allan, RP Howlin, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 527-534, 2015 | 19 | 2015 |
| COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study M Shaunak, R Patel, C Driessens, L Mills, A Leahy, D Gbesemete, ... BMJ open 11 (3), e044899, 2021 | 17 | 2021 |
| Safety and high level efficacy of the combination malaria vaccine regimen of RTS, S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP T Rampling, K Ewer, G Bowyer, C Bliss, N Edwards, D Wright, R Payne, ... Journal of Infectious Diseases, 2016 | 14 | 2016 |
